technetium tc-99m red blood cell kit
Trade name: ultratag
Small moleculeapproved
Approved
Jun 10, 1991
Clinical trial activity
0 trials · 0 clinical orgs · 2 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Timeline
1990s
- Jun 10, 1991
Curium Pharma — Earliest FDA Approval
- Jun 10, 1991
Curium Pharma — NDA Secondary Org
- Jun 10, 1991
Curium Pharma — NDA Organization
- Jun 11, 1992
Cadema Medical Products Inc — NDA Secondary Org
Indications
Approved for
Mechanism of action
- Unspecified targetOTHER
Diagnostic agent
- contrast mediumRadiopaque
contrast medium radiopaque
Approval history
- approvedJun 10, 1991
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Delivery
- Parenteral
- Availability
- Prescription Only
Oral
No
Parenteral
Yes
Topical
No
Sources
- NCATSD8L75GM22O ↗
- ChEMBLCHEMBL1201527 ↗
Also known as
- rbc-scan
- technetium (99mtc) red blood cells
- technetium tc 99m-labeled red blood cells
- technetium tc-99m red blood cell
- technetium tc-99m red blood cell
- technetium tc-99m red blood cell human
- technetium tc 99m red blood cell kit
- technetium tc-99m red blood cell kit
- technetium tc-99m red blood cell kit
- technetium tc-99m red blood cell kit
- technetium tc 99m red blood cells
- technetium tc 99m red blood cells
- technetium tc-99m red blood cells
- ultratag
- ultratag
- ultratag rbc
Organizations
Marketing (3)
| Organization | Org type | Relationship | Date |
|---|---|---|---|
| Cadema Medical Products Inc | For profit | NDA2 | Jun 11, 1992 |
| Curium Pharma | For profit | NDA2 | Jun 10, 1991 |
| Curium Pharma | For profit | NDA | Jun 10, 1991 |